Home | Join Now | Print Page | Report Abuse | Sign In
Long Acting Injectables Conference - CANCELLED
Tell a Friend About This EventTell a Friend
 

This event will be rescheduled for next Spring.

11/13/2019
When: Wednesday, November 13, 2019
1:00 pm – 5:00 pm (Central Time)
Where: Ewald Consulting
1000 Westgate Drive
Conference Center
St. Paul, Minnesota  55114
United States
Contact: 651-697-1771

« Go to Upcoming Event List  

MPhA Conference: Long-Acting Injectable Antipsychotics and Extended-Release Naltrexone

Essentials for the Pharmacist

Description

A review of the FDA-approved indications and use of long-acting injectable antipsychotics and extended-release naltrexone in the appropriate patient populations. Mechanism of action, dose, frequency, need for oral medication overlap and adverse effects will be explored. Participants will compare and contrast the different long-acting injectable antipsychotics and identify which agent(s) may be most appropriate based on patient characteristics. Participants will identify patients who may benefit from extended-release naltrexone and when initiation of extended-release naltrexone is appropriate. Finally, participants will be able to list advantages and disadvantages to the use of long-acting injectable antipsychotics and extended-release naltrexone to identify possible motivations for patient acceptance of these agents.

Objectives

  1. Review the FDA-approved indications, mechanism of action, pharmacokinetics, and use of long-acting injectable antipsychotic agents and extended-release naltrexone.
  2. Explore advantages for patients for the use of long-acting injectable antipsychotics and extended-release naltrexone.
  3. Compare and contrast different long-acting injectable antipsychotics and determine which agent(s) may be most appropriate based on patient characteristics.
  4. Review adverse effects of long-acting injectable antipsychotics and extended-release naltrexone and develop a monitoring plan and strategies to minimize adverse effects.

Speaker

Amie Jo Digatono, PharmD

Amie Jo Digatono, PharmD, graduated from the University of Minnesota College of Pharmacy in 2011. She is a Board-Certified Psychiatric Pharmacist with experience treating patients with severe and persistent mental illness in a state behavioral health hospital and in community hospital inpatient units. Her experience also includes caring for patients with substance use disorders as well as dual diagnosis patients (those with co-occurring behavioral health and substance use disorders). She serves on the Century Mortar Club Board of Directors at the University of Minnesota, volunteers as a peer reviewer for the College of Psychiatric and Neurologic Pharmacists, and serves as an election judge with the city of Minneapolis. Dr. Digatono lives in Northeast Minneapolis where she herds two free-spirited tomcats and tends to an unruly native wildflower garden.

    Minnesota Pharmacists Association

     

    1000 Westgate Drive, Suite 252, St. Paul, MN 55114 | Phone: 651.697.1771 Fax: 650.290.2266 Email: info@mpha.org

    © 2019 MPhA. All Rights Reserved. Site Map. Email Deliverability.